Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T74977 | Target Info | |||
Target Name | Dual specificity protein kinase TTK (MPS1) | ||||
Synonyms |
Tyrosine threonine kinase; Phosphotyrosine picked threonine-protein kinase; PYT; MPS1L1
Click to Show/Hide
|
||||
Target Type | Clinical trial Target | ||||
Gene Name | TTK | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Leucine-rich repeat kinase 2 (LRRK2) | Clinical trial Target | ||||
UniProt ID | LRRK2_HUMAN | |||||
Gene Name | LRRK2 | |||||
Synonyms |
PARK8; Leucine-rich repeat serine/threonine-protein kinase 2; Dardarin
Click to Show/Hide
|
|||||
Representative Drug(s) | BOS172722 | Drug Info | IC50 = 48 nM | [1] | ||
Co-Target Name | Stress-activated protein kinase JNK1 (JNK1) | Clinical trial Target | ||||
UniProt ID | MK08_HUMAN | |||||
Gene Name | MAPK8 | |||||
Synonyms |
Stress-activated protein kinase 1c; SAPK1c; PRKM8; Mitogen-activated protein kinase 8; MAPK 8; MAP kinase 8; JNK-46; C-Jun N-terminal kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | BOS172722 | Drug Info | IC50 = 92 nM | [1] | ||
Co-Target Name | Stress-activated protein kinase JNK2 (JNK2) | Patented-recorded Target | ||||
UniProt ID | MK09_HUMAN | |||||
Gene Name | MAPK9 | |||||
Synonyms |
Stress-activated protein kinase 1a; SAPK1a; PRKM9; Mitogen-activated protein kinase 9; Mitogen-activated protein kinase 8-interacting protein 2; MAPK 9; MAP kinase 9; Jun-N-terminal kinase 2; JNK-interacting protein 2; JNK-55; JNK MAP kinase scaffold protein 2; JIP-2; Islet-brain-2; IB-2; C-jun-amino-terminal kinase interacting protein 2; C-Jun N-terminal kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | BOS172722 | Drug Info | IC50 = 76 nM | [1] | ||
Co-Target Name | Stress-activated protein kinase JNK3 (JNK3) | Patented-recorded Target | ||||
UniProt ID | MK10_HUMAN | |||||
Gene Name | MAPK10 | |||||
Synonyms |
Stress-activated protein kinase 1b; SAPK1b; PRKM10; Mitogen-activated protein kinase 10; MAPK 10; MAP kinase p49 3F12; MAP kinase 10; JNK3A; C-Jun N-terminal kinase 3
Click to Show/Hide
|
|||||
Representative Drug(s) | BOS172722 | Drug Info | IC50 = 242 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 2-Cyclin A2 complex (CDK2-CCNA2) | Co-Target | ||||
UniProt ID | CDK2_HUMAN-CCNA2_HUMAN | |||||
Gene Name | CDK2-CCNA2 | |||||
Representative Drug(s) | BOS172722 | Drug Info | Ki = 510 nM | [1] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4- d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N. J Med Chem. 2018 Sep 27;61(18):8226-40. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.